Semaglutide Users Had Higher NAION Risk in T2DM Tags Nonarteritic Ischemic Optic Neuropathy GLP-1 agonists Read more about Semaglutide Users Had Higher NAION Risk in T2DM
Vitamin D Deficiency Was Associated With Thyroid Markers in T2DM Tags THYROID PROFILE Read more about Vitamin D Deficiency Was Associated With Thyroid Markers in T2DM
Tirzepatide Outperformed Conventional Care in Early T2DM Tags GLP-1 agonists Read more about Tirzepatide Outperformed Conventional Care in Early T2DM
SGLT2 Inhibitors Lowered Liver Enzymes More Than GLP-1 RAs Tags GLP-1 agonists SGLT-2 Inhibitor Read more about SGLT2 Inhibitors Lowered Liver Enzymes More Than GLP-1 RAs
Empagliflozin Improved Insulin Resistance More Than Sitagliptin Tags SGLT-2 Inhibitor Read more about Empagliflozin Improved Insulin Resistance More Than Sitagliptin
Experts Endorsed SGLT2i Before GLP-1 RA in CKD and T2DM Tags CKD Diabetic Nephropathy GLP-1 agonists SGLT-2 Inhibitor Read more about Experts Endorsed SGLT2i Before GLP-1 RA in CKD and T2DM
Postmenopausal Women With Low Vitamin D Had Higher HOMA-IR Read more about Postmenopausal Women With Low Vitamin D Had Higher HOMA-IR
SGLT2 Inhibitors Were Linked to Lower Epilepsy Risk in T2DM Tags DPP-4 inhibitors SGLT-2 Inhibitor Read more about SGLT2 Inhibitors Were Linked to Lower Epilepsy Risk in T2DM
GLP-1RAs Showed Favorable Liver Outcomes Signal in T2DM Tags MASLD/MASH GLP-1 agonists Read more about GLP-1RAs Showed Favorable Liver Outcomes Signal in T2DM
Injectable Semaglutide, Efpeglenatide Led MACE Profiles in T2DM Tags Coronary artery disease Stroke GLP-1 agonists Read more about Injectable Semaglutide, Efpeglenatide Led MACE Profiles in T2DM